Thursday, 15 June 2017

University of Bath

Scientists and engineers from the University of Bath, UK, have developed biodegradable cellulose microbeads from a sustainable source that could potentially replace harmful plastic ones that contribute to ocean pollution.

Microbeads are little spheres of plastic less than 0.5 mm in size that are added to personal care and cleaning products including cosmetics, sunscreens and fillers to give them a smooth texture. However they are too small to be removed by sewage filtration systems and so end up in rivers and oceans, where they are ingested by birds, fish and other marine life.

It is estimated that a single shower can result in 100,000 plastic particles entering the ocean, contributing to the eight million tonnes of plastic that enters the ocean every year. It is feared that the particles could enter the food chain, harming wildlife but also potentially ending up in our food.

As a result of recent campaigning by environmental groups, the UK Government has pledged to ban plastic microbeads in 2017.

Now a research team, from the University’s Centre for Sustainable Chemical Technologies (CSCT), has developed a way of producing a biodegradable renewable alternative to plastic microbeads in a scalable, continuous manufacturing process.

The beads are made from cellulose, which is the material that forms the tough fibres found in wood and plants. In this process our scientists dissolve the cellulose to reform it into tiny beads by forming droplets that are then ‘set’. These microbeads are robust enough to remain stable in a bodywash, but can be broken down by organisms at the sewage treatment works, or even in the environment in a short period of time.

The researchers anticipate they could use cellulose from a range of ‘waste’ sources, including from the paper making industry as a renewable source of raw material.

Dr Janet Scott, reader in the department of chemistry and part of the CSCT, said, “Microbeads used in the cosmetics industry are often made of polyethylene or polypropylene, which are cheap and easy to make. However these polymers are derived from oil and they take hundreds of years to break down in the environment. We have developed a way of making microbeads from cellulose, which is not only from a renewable source, but also biodegrades into harmless sugars. We hope in the future these could be used as a direct replacement for plastic microbeads.”

Davide Mattia, professor of Chemical Engineering and part of the CSCT, said, “Our goal was to develop a continuous process that could be scaled for manufacturing. We achieved this by working together from the start, integrating process design and chemistry optimisation, showing the strength of the multi-disciplinary approach we have in the CSCT.”

The beads are made using a solution of cellulose which is forced through tiny holes in a tubular membrane, creating spherical droplets of the solution which are washed away from the membrane using vegetable oil. The beads are then collected, set and separated from the oil before use.

The physical properties of the beads can be tweaked by changing the structure of the cellulose, for example making the beads harder. A team, led by Dr Scott and including Professor Davide Mattia (chemical engineering) and Professor Karen Edler (chemistry) has also just been awarded funding of just over £ 1 million by the Engineering & Physical Sciences Research Council to develop porous beads, capsules and microsponges.

They will work with industrial partners, to develop materials that could be used in cosmetics and personal care products, or impregnated with agrichemicals for use in, for example, slow release fertilisers.

University of Liverpool

Are you considering joining the first fully accredited Master of Science degree programme in International Trade Compliance?

FCC worked in partnership with the University of Liverpool to develop a program which combines instruction in U.S., E.U. and international trade regulations with practical business management techniques. The lecturers and guest speakers are industry experts and senior government officials and include James E. Bartlett III, partner at FCC.

The program is run in the University of Liverpool’s London campus, and consists of eight one-week classroom sessions, spread over a two year period, thus enabling you to continue working while earning a master’s degree. Your thesis would be a project to assist your current, or any future, employer design or improve an international trade compliance program.

The next intake of students for the University of Liverpool’s Executive Masters in International Trade Compliance is September 2017.

For more information please visit the University of Liverpool’s website or send an email to exed@liverpool.ac.uk.  We are looking forward to meeting you and assisting you in taking your career to the next level!

University of Aberdeen

Laura Machado discusses clinical trials and how the DECIDE project at the University of Aberdeen aims to make information more widely available. To find out about how to test medicines and explore the fascinating secrets of the NHS Grampian archives join us from 2pm on EXPLORATHON on the 25 September in the main entrance foyer at Union Square in Aberdeen. This blog is taken from the EXPLORATHON magazine which you can read in full online or pick up a copy on the night of EXPLORATHON!

We all rely on medicine – from the ibuprofen you take on a rough morning to the anti-allergenic that inhabits the kitchen cupboard when the pollen season arrives. This is how clinical trials pervade every aspect of modern medicine, but have you ever thought about the process behind getting safe and effective drugs from a laboratory to your medicine cabinet?

Only when drugs have proven to be safe they are released into the market. Nevertheless, despite being at the heart of clinical practice, clinical trials remain a mystery to many. Although the importance of clinical trials is undeniable, there is a huge gap in public knowledge about the different stages and rationale behind them. Perhaps the input from patients and the public in general has been underestimated: it is their personal experiences with particular illnesses that actually make them a crucial pillar in trial design to make it pertinent. For example, in a trial evaluating medicine for diabetes, “What is it like to suffer from diabetes?”, “What is it like to take care of someone suffering from diabetes?” are questions that need input from experts, and those experts are the public and the patients, not the trial designers.

The main reason, however, of why trials lack participation is that they might appear risky; the idea of being an experimental guinea pig is daunting to most. Conversely, evidence shows that people in a trial receive a quality of care that is, at least as good, if not better, than that of people receiving treatment through routine clinical practice, as explained by Professor Shaun Treweek, of the Health Services Research Unit at the University of Aberdeen. Much of the apparent riskiness stems from the fact that these risks, however small, are made explicit by the trial staff. On the other hand, information provided in routine care can be much less overt in presenting the potential side effects of treatment. Professor Treweek explains, “I can understand why people might think that risk is a problem in trials but the same risks often exist in routine care – although they might not be made as obvious as they are within a trial”.

Parallel to his work on improving clinical trials, Professor Treweek is involved in the DECIDE project. This project aims to tackle a common problem in modern medicine: how routine care is frequently a one-sided affair between patient and doctor. As patients we might look on the internet for information but it is often unreliable, vague and sometimes contradictory. Therefore, health professionals still hold a gate-keeping role to treatments and reliable information based on their expertise and guidelines.

Indeed, in many consultations, the patient’s input is usually minimal–albeit with a few exceptions–as reading scientific papers can be quite tricky for non-specialists. This is where the DECIDE project, which Professor Treweek is involved in, enters the scene.

The DECIDE project seeks to summarise research information. This will allow people to make educated healthcare decisions in synergy with a medical professional. The aim is to design a platform in order to help people access healthcare information that is more targeted at them, but which is still based on well-monitored guidelines and up-to-date research.

DECIDE is an international effort, with the focus of work varying between countries. Researchers in Norway, for example, have linked electronic medical record systems to online guidelines. This allows health professionals to link the two during consultations with patients. Scotland’s own wide use of electronic medical records means it is possible to imagine discussing treatments with concise, clear information based on your own medical history together with your GP. Now it is not so difficult to imagine a better, more efficient, evidence-informed healthcare system that excels not only in its treatments but also in the way they are discussed and delivered.

Cardiff University

QUICK INFO

Location: Cardiff, Wales, United Kingdom
Terms Offered: Spring, Year (Fall and Spring)
Program Type: Exchange
Academic Areas: Engineering, Bioengineering, Civil and Environmental Engineering, Electrical and Computer Engineering, Industrial Engineering, Mechanical Engineering and Materials Science, European Studies
Dates: Spring semester or Academic Year -
Estimated Cost: Pitt's Tuition and Fees; additional costs listed below
Application Deadline: Spring: 26 September | Fall/Academic Year: 20 February
Requirements:
JUMP TO:

Location Information
Academics
Student Life
Faculty
Housing
Pricing and Dates
Pitt Contacts

PROGRAM OVERVIEW

Founded in 1883, Cardiff University is a member of the prestigious Russell Group, placing it among the top 20 research-led universities in the United Kingdom.  Located in and around the portland stone buildings, parks, and tree-lined avenues of Cardiff’s magnificent civic center, the University is home to more than 27,000 students, including 3,000 students from outside the European Union.

Cardiff University is a member of Global E3, an exchange program of Engineering Schools from around the world. More than 60 universities worldwide—33 in the United States and 31 in Asia, Australia, Europe, Latin America, and the Middle East—comprise the Global E3 consortium. This consortium is administered by the Institute of International Education (IIE).

Academic Calendar:

Fall: late September to January
Spring: late January to mid June
Application requirements include:

SSoE student in good standing
Minimum 2.50 GPA for engineering students
Sophomore standing or higher
You must first be accepted by the Swanson School of Engineering International Programs Office , then you will be directed to apply to Global E3. Prior to being accepted, please visit the Global E3 website and read the application instructions and application deadlines. In the past, application deadlines have been October 1st for spring semester programs and March 1st for fall semester programs.

Each university might have an additional application.  Please refer to Cardiff University's website for details. 

Lancaster University

A school of international business in London. The London Business School is also a constituent college of the University of London. The school is consistently ranked as one of the top business schools in the world and offers a very prestigious MBA program.
BREAKING DOWN 'London Business School'
London Business School's vision is to have a profound impact on the way the world does business. The School is consistently ranked among the best in the world for its full-time MBA program. In research, the School is ranked top 10 and holds the highest average research score of any U.K. academic institution.
The School's faculty, from over 30 countries, is grouped into seven subject areas: Accounting, Economics, Finance, Management Science and Operations, Marketing, Organizational Behavior, and Strategy and Entrepreneurship. Additionally it has four research centers: Aditya Birla India Center, Center for Corporate Governance, Coller Institute of Private Equity and Deloitte Institute of Innovation and Entrepreneurship.
Studying at the School provides access to an unmatched diversity of thought. With a presence in four international cities - London, New York, Hong Kong and Dubai - the School is well positioned to equip students from more than 100 countries with the capabilities needed to operate in today's business environment. Students further benefit from 33,500 alumni from more than 130 countries, who provide a wealth of knowledge, business experience and worldwide networking opportunities.
The School awards over 1,000 degrees every year, across MBA, Executive MBA, EMBA-Global, Masters in Finance, Masters in Management, Sloan MSc and PhD programs. The Executive Education team offers a portfolio of over 25 open programs as well as custom-designed programs developed to meet the specific needs of individuals and their organizations. Annually, over 7,000 participants attend executive programs that are led by many of the world's leading business thinkers.